Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jacobson Pharma Corporation Limited ( (HK:2633) ) has issued an update.
Jacobson Pharma Corporation Limited has announced a final ordinary cash dividend of HKD 0.055 per share for the financial year ending March 31, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may enhance its attractiveness to investors, potentially impacting its market positioning positively.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited operates in the pharmaceutical industry, focusing on the development, production, and distribution of a wide range of generic drugs and over-the-counter products. The company is positioned in the Hong Kong market, catering to healthcare needs with its diverse pharmaceutical offerings.
Average Trading Volume: 880,176
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.57B
Find detailed analytics on 2633 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue